Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02FAA
|
|||
| Drug Name |
PMID27336223-Compound-4
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
KEMPHYS LTD
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C22H25NO3
|
|||
| Canonical SMILES |
CC1(CCC(C2=C1C=CC(=C2)NC(=O)C3=CC=C(C=C3)C(=O)O)(C)C)C
|
|||
| InChI |
1S/C22H25NO3/c1-21(2)11-12-22(3,4)18-13-16(9-10-17(18)21)23-19(24)14-5-7-15(8-6-14)20(25)26/h5-10,13H,11-12H2,1-4H3,(H,23,24)(H,25,26)
|
|||
| InChIKey |
MUTNCGKQJGXKEM-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 94497-51-5
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:32181
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Retinoic acid receptor alpha (RARA) | Target Info | Agonist | [1] |
| Target's Patent Info | Retinoic acid receptor alpha (RARA) | Target's Patent Info | [1] | |
| KEGG Pathway | Pathways in cancer | |||
| Transcriptional misregulation in cancer | ||||
| Acute myeloid leukemia | ||||
| Pathway Interaction Database | Retinoic acid receptors-mediated signaling | |||
| Reactome | Nuclear Receptor transcription pathway | |||
| WikiPathways | Vitamin A and Carotenoid Metabolism | |||
| Nuclear Receptors in Lipid Metabolism and Toxicity | ||||
| Integrated Pancreatic Cancer Pathway | ||||
| Adipogenesis | ||||
| Nuclear Receptors | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Therapeutic use of selective synthetic ligands for retinoic acid receptors: a patent review.Expert Opin Ther Pat. 2016 Aug;26(8):957-71. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.